5MZP image
Deposition Date 2017-02-01
Release Date 2017-07-26
Last Version Date 2024-10-16
Entry Detail
PDB ID:
5MZP
Title:
Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with caffeine at 2.1A resolution
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Escherichia coli (Taxon ID: 562)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.21
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
C 2 2 21
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a
Gene (Uniprot):cybC, ADORA2A
Mutagens:A54L, T88A, R107A, K122A, N154A, L202A, M1007W, L235A, V239A, S277A, G318A,A54L, T88A, R107A, K122A, N154A, L202A, M1007W, L235A, V239A, S277A, G318A,A54L, T88A, R107A, K122A, N154A, L202A, M1007W, L235A, V239A, S277A, G318A
Chain IDs:A
Chain Length:433
Number of Molecules:1
Biological Source:Homo sapiens, Escherichia coli
Primary Citation
Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity.
Structure 25 1275 1285.e4 (2017)
PMID: 28712806 DOI: 10.1016/j.str.2017.06.012

Abstact

The adenosine A1 and A2A receptors belong to the purinergic family of G protein-coupled receptors, and regulate diverse functions of the cardiovascular, respiratory, renal, inflammation, and CNS. Xanthines such as caffeine and theophylline are weak, non-selective antagonists of adenosine receptors. Here we report the structure of a thermostabilized human A1 receptor at 3.3 Å resolution with PSB36, an A1-selective xanthine-based antagonist. This is compared with structures of the A2A receptor with PSB36 (2.8 Å resolution), caffeine (2.1 Å), and theophylline (2.0 Å) to highlight features of ligand recognition which are common across xanthines. The structures of A1R and A2AR were analyzed to identify the differences that are important selectivity determinants for xanthine ligands, and the role of T2707.35 in A1R (M2707.35 in A2AR) in conferring selectivity was confirmed by mutagenesis. The structural differences confirmed to lead to selectivity can be utilized in the design of new subtype-selective A1R or A2AR antagonists.

Legend

Protein

Chemical

Disease

Primary Citation of related structures